Breast Cancer Survivors Who Experience Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS)
Clinical trial NCT06106282 · COMPLETED
Trial details
- NCT number
- NCT06106282
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-07-12
- Primary completion
- 2025-10-27
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.